Clinical Trial Update: BMS-247550 in Treating Patients With Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports results from a Phase 2 study of BMS-247550 in patients with advanced pancreatic cancer. The trial status was completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• BMS-247550

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED